MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial

Background and purpose Treatments to facilitate recovery after traumatic brain injury (TBI) are urgently needed. We conducted a 9‐month pilot, randomized placebo‐controlled clinical trial to examine the safety and potential effects of the herbal supplement MLC901 (NeuroAiD II™) on cognitive function...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of neurology Vol. 25; no. 8; pp. 1055 - e82
Main Authors:	Theadom, A., Barker‐Collo, S., Jones, K. M., Parmar, P., Bhattacharjee, R., Feigin, V. L.
Format:	Journal Article
Language:	English
Published:	England John Wiley & Sons, Inc 01.08.2018 John Wiley and Sons Inc
Subjects:	Adults Anxiety Brain Central nervous system Clinical trials Cognition Cognitive ability cognitive deficits Complications Concussion Executive function Fatigue Fatigue failure Head injuries Herbal medicine Mental depression MLC901 Mood NeuroAiD II Original Quality of life Traumatic brain injury traumatic brain injury cognitive deficits concussion quality of life MLC901 NeuroAiD II
ISSN:	1351-5101, 1468-1331, 1468-1331
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!